University of North Carolina at Chapel Hill- CGIBD — Chapel Hill, North Carolina

University of North Carolina at Chapel Hill- CGIBD is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

University of North Carolina at Chapel Hill- CGIBD has participated in 1 clinical trials.

Therapeutic areas: Inflammatory Bowel Diseases, Crohns Disease, Ulcerative Colitis.

Sponsors: University of North Carolina, Chapel Hill.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of North Carolina at Chapel Hill- CGIBD?

University of North Carolina at Chapel Hill- CGIBD has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of North Carolina at Chapel Hill- CGIBD conducted?

University of North Carolina at Chapel Hill- CGIBD has 1 clinical trials on record. Their work covers Inflammatory Bowel Diseases, Crohns Disease, Ulcerative Colitis.

Is University of North Carolina at Chapel Hill- CGIBD accredited by Crixeo Health?

University of North Carolina at Chapel Hill- CGIBD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of North Carolina at Chapel Hill- CGIBD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.